M A Brown
Impact in
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
- Oncology 10
- Peptidase Inhibition and Analysis 10
-
- Biochemical and Structural Characterization 4
- Co-authors
- A. John Barrett (13 shared papers)A A Kembhavi (2 shared papers)Christopher G. Knight (3 shared papers)Heidrun Kirschke (1 shared paper)Motoki Tamai (1 shared paper)Kazunori Hanada (1 shared paper)Neil D. Rawlings (2 shared papers)Martin J.H. Nicklin (1 shared paper)
- Journals
- Biochemical Journal (9 papers)Thrombosis Research (1 paper)Journal of Biological Chemistry (1 paper)Journal of Toxicology and Environmental Health (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
M A Brown
16 papers receiving 2.4k citations
M A Brown's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 574
- Oncology 598
- Biotechnology 201
- Hematology 236
- Genetics 209
Countries citing papers authored by M A Brown
This map shows the geographic impact of M A Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M A Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M A Brown more than expected).
Fields of papers citing papers by M A Brown
This network shows the impact of papers produced by M A Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M A Brown. The network helps show where M A Brown may publish in the future.
Co-authors
The 25 scholars most cited alongside M A Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L Hit paper breakdown → | 1982 | 934 |
| 2 | The electrophoretically ‘slow’ and ‘fast’ forms of the α2-macroglobulin molecule Hit paper breakdown → | 1979 | 500 |
| 3 | 1997 | 310 | |
| 4 | 1983 | 275 | |
| 5 | 1986 | 76 | |
| 6 | 1995 | 75 | |
| 7 | 1993 | 72 | |
| 8 | 1993 | 55 | |
| 9 | 1984 | 49 | |
| 10 | 1990 | 44 | |
| 11 | 1987 | 38 | |
| 12 | 1989 | 30 | |
| 13 | 1988 | 21 | |
| 14 | 1992 | 9 | |
| 15 | 1995 | 9 | |
| 16 | 1995 | 5 |
About M A Brown
M A Brown is a scholar working on Oncology, Molecular Biology, Cellular and Molecular Neuroscience, Genetics and Cancer Research, having authored 16 papers that have together received 2.5k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (10 papers), Biochemical and Structural Characterization (4 papers), Neuropeptides and Animal Physiology (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Protease and Inhibitor Mechanisms (3 papers), Adenosine and Purinergic Signaling (2 papers), Amoebic Infections and Treatments (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Cancer Research (574 citations), Oncology (598 citations), Biotechnology (201 citations), Hematology (236 citations) and Genetics (209 citations). M A Brown has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include A. John Barrett, A A Kembhavi, Christopher G. Knight, Heidrun Kirschke, Motoki Tamai, Kazunori Hanada, Neil D. Rawlings, Martin J.H. Nicklin, David C. Sunter and Jinq-May Chen. Their work appears in journals such as Biochemical Journal, Thrombosis Research, Journal of Biological Chemistry, Journal of Toxicology and Environmental Health and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.